HLB Genex, Inc. (KOSDAQ:187420)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,325.00
+55.00 (2.42%)
At close: May 20, 2026
Market Cap70.12B -30.7%
Revenue (ttm)43.37B +22.4%
Net Income22.59B
EPS606.00
Shares Out30.16M
PE Ratio3.84
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume464,716
Average Volume221,165
Open2,270.00
Previous Close2,270.00
Day's Range2,180.00 - 2,500.00
52-Week Range2,180.00 - 3,785.00
Beta0.16
RSI29.32
Earnings DateMay 21, 2026

About HLB Genex

HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phytosphingosine and vitamin K2. The company also develops drug candidates for wet and dry macular degeneration, inflammatory bowel disease, anticancer, o... [Read more]

Industry Industrial Organic Chemicals
Founded 2000
Employees 75
Stock Exchange KOSDAQ
Ticker Symbol 187420
Full Company Profile

Financial Performance

Financial Statements